AnalystsMark BreidenbachMark Breidenbach's Stock Forecasts
AnalystsMark Breidenbach
Sectors:
Industries:
Analyst Ranking
Top 9%
#414 out of 4595 analysts
Average Return
+22.84%
Win Rate
40%25 out of 63
Risk vs Reward
Poor
Good
Mark Breidenbach's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +493.88% | $10.94 | $64.97 | 2023-06-26 - 2024-05-17 | Buy |
Seres Therapeutics IncMCRB | +476.75% | $3.57 | $20.59 | 2020-03-31 - 2021-03-31 | Buy |
Alpine Immune Sciences IncALPN | +428.05% | $7.45 | $39.34 | 2023-03-24 - 2024-03-22 | Buy |
Alpine Immune Sciences IncALPN | +405.60% | $12.85 | $64.97 | 2023-09-11 - 2024-05-17 | Buy |
Compugen LtdCGEN | +225.32% | $0.79 | $2.57 | 2023-02-28 - 2024-02-28 | Buy |
Mark Breidenbach Analyst Color
Get additional color on Mark Breidenbach's coverage of popular stocks
Mark Breidenbach's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Allogene Therapeutics IncALLO | 5 | Buy | $13.00 | +420.00% | Maintains | 13 days ago |
Essa Pharma IncEPIX | 4 | Buy | $17.00 | +151.85% | Reiterates | 6 months ago |
Alpine Immune Sciences IncALPN | 4 | Buy | $22.00 | -66.14% | Maintains | 9 months ago |
Arvinas IncARVN | 5 | Buy | $95.00 | +186.66% | Reiterates | 10 months ago |
Immuneering CorpIMRX | 3 | Buy | $25.00 | +1,698.56% | Reiterates | 10 months ago |
Cue Biopharma IncCUE | 5 | Buy | $10.00 | +513.50% | Assumes | a year ago |
Seres Therapeutics IncMCRB | 4 | Buy | $12.00 | +1,100.00% | Assumes | a year ago |
Nurix Therapeutics IncNRIX | 2 | Buy | $25.00 | +58.73% | Assumes | a year ago |
Biolinerx LtdBLRX | 1 | Buy | $4.00 | N/A | Reiterates | a year ago |
Gamida Cell LtdGMDAQ | 4 | Buy | $6.00 | N/A | Maintains | a year ago |
Compugen LtdCGEN | 6 | Buy | $7.00 | N/A | Maintains | a year ago |
Caribou Biosciences IncCRBU | 2 | Buy | $32.00 | N/A | Maintains | a year ago |
Syros Pharmaceuticals IncSYRS | 3 | Buy | $13.00 | N/A | Maintains | a year ago |
Iovance Biotherapeutics IncIOVA | 5 | Buy | $15.00 | N/A | Maintains | a year ago |
Synlogic IncSYBX | 2 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Forma Therapeutics Holdings IncFMTX | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Global Blood Therapeutics IncGBT | 2 | Buy | $86.00 | N/A | Maintains | 2 years ago |
Kadmon Holdings IncKDMN | 1 | Buy | $9.00 | N/A | Maintains | 3 years ago |
Achilles Therapeutics PLCACHL | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 3 years ago |
Mustang Bio IncMBIO | 2 | Buy | $195.00 | N/A | Maintains | 4 years ago |
Bluebird Bio IncBLUE | 2 | Buy | $135.00 | N/A | Upgrades | 4 years ago |
Sorrento Therapeutics IncSRNEQ | 1 | Buy | $6.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.